Ignite Creation Date:
2024-05-06 @ 12:54 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03882255
Status:
COMPLETED
Last Update Posted:
2019-10-09
First Post:
2019-03-18
Brief Title:
A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium
Study Overview
Official Title:
A Randomized Double-blind Parallel-group 2-period Placebo-controlled Phase 1 Study to Investigate the Effects on Heart Rate Blood Pressure and Pharmacokinetic Interactions of the Up-titration Regimen of Ponesimod in Healthy Adult Subjects Receiving Propranolol at Steady State
Status:
COMPLETED
Status Verified Date:
2019-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to evaluate the effect of the up-titration regimen of ponesimod on heart rate HR and other electrocardiogram ECG parameters when administrated to healthy adult participants receiving propranolol at steady state
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2018-003550-24 | EUDRACT_NUMBER | None | None |
| AC-058-117 | OTHER | Janssen Pharmaceutica NV Belgium | None |